June 23, 2017 / 3:40 PM / in 4 months

BRIEF-Horizon Pharma sees 2017 net sales between $985 mln - $1.02 bln

June 23 (Reuters) - Horizon Pharma Plc:

* Full-year 2017 net sales are now expected to be in a range of $985 million to $1.020 billion

* Full-year 2017 adjusted ebitda guidance range of $315 million to $350 million has not changed Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below